These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1367365)

  • 1. Aspects of biotechnology in a united Germany.
    Schmid RD; Rehm HJ
    Appl Microbiol Biotechnol; 1991 May; 35(2):135-43. PubMed ID: 1367365
    [No Abstract]   [Full Text] [Related]  

  • 2. Q&A: Horst Domdey.
    Wald C
    Nature; 2016 May; 533(7601):S30-1. PubMed ID: 27144606
    [No Abstract]   [Full Text] [Related]  

  • 3. BIO marches to Congress with growth package in hand.
    Carey K
    Nat Biotechnol; 2011 Sep; 29(9):776-7. PubMed ID: 21904306
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefits of biotech clusters questioned.
    Sheridan C
    Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategic rethink for German biotechnology.
    Fernandes M; Miska D
    Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106
    [No Abstract]   [Full Text] [Related]  

  • 6. Malyasian biotechnology: the valley of ghosts.
    Cyranoski D
    Nature; 2005 Aug; 436(7051):620-1. PubMed ID: 16079812
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech project in turmoil as Michigan balances books.
    Knight J
    Nature; 2003 Mar; 422(6928):102. PubMed ID: 12634742
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech parks proliferate, despite concerns over sustainability.
    Jia H; Jayaraman KS; Orellana C
    Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
    [No Abstract]   [Full Text] [Related]  

  • 9. Building cooperation New York.
    Smaglik P
    Nature; 2002 Sep; 419(6905):4-5. PubMed ID: 12352990
    [No Abstract]   [Full Text] [Related]  

  • 10. Building Nordic networks.
    Smaglik P
    Nature; 2002 Dec; 420(6916 Suppl):A3, A5, A7. PubMed ID: 12501120
    [No Abstract]   [Full Text] [Related]  

  • 11. A European heavyweight.
    Boytchev H
    Nature; 2018 Nov; 563(7729):S14-S15. PubMed ID: 30382228
    [No Abstract]   [Full Text] [Related]  

  • 12. Germany reattempts to spark innovation.
    Habeck M
    Nat Biotechnol; 2004 Mar; 22(3):257-8. PubMed ID: 14990939
    [No Abstract]   [Full Text] [Related]  

  • 13. Florida lures research institutes east.
    Dalton R
    Nature; 2006 Aug; 442(7104):729. PubMed ID: 16915254
    [No Abstract]   [Full Text] [Related]  

  • 14. A plea for funding 'small' basic research in Europe. Practical proposals for the next EU Framework Programme.
    Goffeau A
    EMBO Rep; 2001 Dec; 2(12):1057-60. PubMed ID: 11743012
    [No Abstract]   [Full Text] [Related]  

  • 15. European biotechnology turns East.
    Sansom C
    Nat Biotechnol; 1999 May; 17(5):437-9. PubMed ID: 10331797
    [No Abstract]   [Full Text] [Related]  

  • 16. Legal and social aspects of biotechnology in Poland.
    Twardowski T
    Acta Biochim Pol; 2005; 52(3):III-V. PubMed ID: 16475253
    [No Abstract]   [Full Text] [Related]  

  • 17. Taiwan: Biotech vision.
    Cyranoski D
    Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
    [No Abstract]   [Full Text] [Related]  

  • 18. Germany contemplates new biotech tax scheme.
    Mitchell P
    Nat Biotechnol; 2003 Jun; 21(6):587-8. PubMed ID: 12776130
    [No Abstract]   [Full Text] [Related]  

  • 19. Australia. Last-ditch effort to save center at vanguard of stem cell research.
    Finkel E
    Science; 2008 Oct; 322(5901):524-5. PubMed ID: 18948515
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of the "new science" of genomics.
    Coile RC
    J Healthc Manag; 2001; 46(6):365-8. PubMed ID: 11729566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.